FindTrial
Sign In

A Comparative study between two nebulizers used to reduce post operative Sore Throat in laparoscopic surgeries.

A Comparative study of Dexemedetomidine and Ketamine given as nebulisation to attenuate post operative sore throat in patients undergoing laparoscopic surgeries under General Anaesthesia - A Prospective randomized double blind study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/049066
Enrollment
70
Registered
2023-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Ketamine with Normal saline: Single dose Nebulisation of Ketamine 50mg (1ml) with Normal saline (4ml) Control Intervention1: Dexmedetomidine with Normal saline: Single dose Nebulisation

Sponsors

Dr Sumiya Sultana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing to give informed and written consent. 2.American Society of Anaesthesiologists physical status I & II. 3.Patients with Body Mass Index(BMI) >18.5 kg/m2 to <29.9 kg/m2.

Exclusion criteria

Exclusion criteria: 1. Patients who have known hypersensitivity to dexmedetomidine or ketamine. 2. Patients with Mallampati grade >2. 3. Patients with difficult airway who need more than 2 attempts of intubation. 4. Obese Individuals (Body mass Index >30.0 kg/m2). 5. Patients with history of upper respiratory tract infection / Eosinophilia. 6. Patients who developed intraoperative or postoperative complications. 7. Pregnancy or lactating mothers. 8. Patients with cardiac, respiratory, hepatic, renal, neurological and psychiatric illness.

Design outcomes

Primary

MeasureTime frame
Post operative sore throat scale is measuredTimepoint: 0 hours,2 hours,4 hours,6 hours,12 hours and 24 hours—

Secondary

MeasureTime frame
Hemodynamic parametersTimepoint: 0 hours,2 hours,4 hours,6 hours,12 hours and 24 hours—

Countries

India

Contacts

Public ContactDr Ramesh Kumar P B

BGS Global Institute of Medical Sciences

sumiyasultana28@gmail.com9916595681

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026